Ligand validation:3OSK

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3OSK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OSK_NAG_A_131	86%	57%	0.08	0.947	0.6	1.06	-	2	0	0	100%	0.9333
3OSK_NAG_B_131	18%	65%	0.209	0.798	0.56	0.78	-	1	0	0	100%	0.9333
7SU0_NAG_C_202	62%	66%	0.127	0.917	0.82	0.51	1	-	2	0	100%	0.9333
6RPJ_NAG_E_201	9%	73%	0.333	0.83	0.29	0.76	-	1	0	0	100%	0.9333
7SU1_NAG_C_201	6%	59%	0.335	0.775	0.82	0.75	1	1	0	0	100%	0.9333
6XY2_NAG_A_201	4%	61%	0.292	0.652	0.87	0.64	1	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.